The FDA has approved Zepatier for the treatment of HCV genotypes 1 and 4 infections. Zepatier has been approved by the FDA to treat hepatitis C virus genotypes 1 and 4 infections in adult patients.

In previous articles of this series, we’ve discussed several aspects of the hepatitis C virus including the nature of the infection and its distribution both globally and in the United States. Most ...

Hepatitis C is a serious blood borne disease that can cause severe liver damage and impacts over 2.5 million Americans. While the disease can be treated, treatment is not yet universally available and ...

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system. Objectives: Direct-acting antivirals ...

The world is celebrating World Hepatitis Day today, i.e, July 28, 2025, which marks the 15th anniversary of World Hepatitis Day. World Hepatitis Day is observed through Resolution WHA63.18 at the 63rd ...

Hepatitis is contagious. It is an inflammation of the liver that results from a virus. There are five types of viral hepatitis, and all are contagious, although they can spread in different ways.